Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Detection of acute HCV infection before the appearance of HCV antibodies in serum (ie, <2 months from exposure)
Detection and confirmation of chronic HCV infection, and determining HCV genotype (1 to 5) to guide antiviral therapy in patients with chronic hepatitis C
Quantification of HCV RNA in serum of patients with chronic HCV infection (HCV antibody-positive) before initiating antiviral therapy
Determining cure and detection of relapse of HCV infection after completion of antiviral therapy
A reflex test for serum specimens that are hepatitis C Virus (HCV) antibody screen-reactive for diagnosis of chronic hepatitis C.
This test is appropriate for diagnosis of acute hepatitis C in high-risk or immunosuppressed individuals who may be negative for HCV antibodies.
This test can be used to establish a baseline HCV viral load and viral genotype before initiating antiviral therapy for chronic hepatitis C.
This test is appropriate for confirming a sustained virologic response and detecting a relapse of hepatitis C after completion of antiviral therapy.
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
HCVG | HCV Genotype, S | Yes | No |
HCVGR | HCV Genotype Resolution, S | No | No |
The following algorithms are available in Special Instructions:
-Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Antigen (DAA) Combination
HCVQG: Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
HCVGR: RT-PCR followed by Hybridization with Sequence-Specific, Fluorescent-Labeled Oligonucleotide Probes